Fouad Alchami

545 total citations
8 papers, 321 citations indexed

About

Fouad Alchami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Fouad Alchami has authored 8 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Fouad Alchami's work include Occupational and environmental lung diseases (3 papers), Advanced Breast Cancer Therapies (2 papers) and Medical Imaging and Pathology Studies (2 papers). Fouad Alchami is often cited by papers focused on Occupational and environmental lung diseases (3 papers), Advanced Breast Cancer Therapies (2 papers) and Medical Imaging and Pathology Studies (2 papers). Fouad Alchami collaborates with scholars based in United Kingdom, Germany and Australia. Fouad Alchami's co-authors include Robert H. Jones, Angela Casbard, Simon Waters, Ramachandran Venkitaraman, Pavel Bezecny, Johnathan Joffe, Margherita Carucci, Rachel Butler, Chris Twelves and C. Bale and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Fouad Alchami

8 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fouad Alchami United Kingdom	6	180	180	135	76	38	8	321
Jaime Miguel Gomes Pita Belgium	7	112 0.6×	119 0.7×	142 1.1×	74 1.0×	15 0.4×	11	318
Pablo Tolosa Spain	8	91 0.5×	154 0.9×	61 0.5×	50 0.7×	29 0.8×	36	229
Elza C. de Bruin United Kingdom	6	112 0.6×	171 0.9×	101 0.7×	140 1.8×	43 1.1×	8	308
M. Campone France	8	86 0.5×	128 0.7×	79 0.6×	44 0.6×	14 0.4×	21	217
Julie Tisserand France	7	104 0.6×	191 1.1×	91 0.7×	84 1.1×	75 2.0×	8	289
Jason Kunisaki United States	4	94 0.5×	63 0.3×	109 0.8×	98 1.3×	24 0.6×	6	236
Sarit Schwartz United States	4	84 0.5×	61 0.3×	149 1.1×	44 0.6×	36 0.9×	8	211
Jason Glover United States	5	79 0.4×	74 0.4×	115 0.9×	72 0.9×	26 0.7×	8	243
Yuto Yasuda Japan	10	172 1.0×	221 1.2×	121 0.9×	62 0.8×	59 1.6×	35	346
Tomoko Funazo Japan	10	172 1.0×	223 1.2×	123 0.9×	62 0.8×	56 1.5×	28	347

Countries citing papers authored by Fouad Alchami

Since Specialization

Citations

This map shows the geographic impact of Fouad Alchami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fouad Alchami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fouad Alchami more than expected).

Fields of papers citing papers by Fouad Alchami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fouad Alchami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fouad Alchami. The network helps show where Fouad Alchami may publish in the future.

Co-authorship network of co-authors of Fouad Alchami

This figure shows the co-authorship network connecting the top 25 collaborators of Fouad Alchami. A scholar is included among the top collaborators of Fouad Alchami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fouad Alchami. Fouad Alchami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Alchami, Fouad, et al.. (2023). Whole Slide Imaging Integration with Lab Information Systems, a Study of the Requirements, Processes and Procedures Enabling a Reporting-Based Workflow. Figshare. Volume 15. 1–11. 2 indexed citations

Jones, Robert H., Angela Casbard, Margherita Carucci, et al.. (2020). Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial. The Lancet Oncology. 21(3). 345–357. 159 indexed citations

Alchami, Fouad, et al.. (2019). Does Simian Virus 40 (SV40) Have a Role in UK Malignant Pleural Mesothelioma? No Role is Identified in a Sensitive RNA In Situ Hybridization Study on Potentially Affected Birth Cohorts. Applied immunohistochemistry & molecular morphology. 28(6). 444–447. 4 indexed citations

Jones, Robert H., Margherita Carucci, Angela Casbard, et al.. (2019). Capivasertib (AZD5363) plus fulvestrant versus placebo plus fulvestrant after relapse or progression on an aromatase inhibitor in metastatic ER-positive breast cancer (FAKTION): A randomized, double-blind, placebo-controlled, phase II trial.. Journal of Clinical Oncology. 37(15_suppl). 1005–1005. 27 indexed citations

Silva, Andreia, Tim Robinson, Angélica Santiago-Gómez, et al.. (2018). Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP. Clinical Cancer Research. 24(10). 2452–2463. 42 indexed citations

Chen, Hung‐Chang, Noémie Joalland, John S. Bridgeman, et al.. (2017). Synergistic targeting of breast cancer stem‐like cells by human γδ T cells and CD8⁺ T cells. Immunology and Cell Biology. 95(7). 620–629. 51 indexed citations

Alchami, Fouad, et al.. (2016). Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma. Journal of Clinical Pathology. 70(2). 179–182. 18 indexed citations

Attanoos, Richard, Fouad Alchami, F D Pooley, & A R Gibbs. (2016). Usual interstitial pneumonia in asbestos‐exposed cohorts – concurrent idiopathic pulmonary fibrosis or atypical asbestosis?. Histopathology. 69(3). 492–498. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact